Eddit
K |
|||
Zeile 3: | Zeile 3: | ||
*'''[[Unproven ideas]]''' | *'''[[Unproven ideas]]''' | ||
*'''[[Reviews on covid19 disease]]''' | *'''[[Reviews on covid19 disease]]''' | ||
+ | {{tp|p=32335367|t=ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response |pdf=|usr=}} | ||
+ | |||
*'''[[Research tools]]''' | *'''[[Research tools]]''' | ||
{{tp|p=32142596|t=2020. Machine Learning, COVID?19 (2019?nCoV), and multi?OMICS |pdf=|usr=}} | {{tp|p=32142596|t=2020. Machine Learning, COVID?19 (2019?nCoV), and multi?OMICS |pdf=|usr=}} | ||
Zeile 13: | Zeile 15: | ||
{{tp|p=32129842|t=ä. A glimpse into the origins of genetic diversity in SARS-CoV-2 |pdf=|usr=}} | {{tp|p=32129842|t=ä. A glimpse into the origins of genetic diversity in SARS-CoV-2 |pdf=|usr=}} | ||
{{tp|p=32229288|t=ä. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy |pdf=|usr=}} | {{tp|p=32229288|t=ä. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy |pdf=|usr=}} | ||
+ | {{tp|p=32341946|t=2020. Chaos game representation dataset of SARS-CoV-2 genome |pdf=|usr=}} | ||
+ | |||
Zeile 24: | Zeile 28: | ||
*'''[[Innate sensing]]''' | *'''[[Innate sensing]]''' | ||
*'''[[Immunology]]''' | *'''[[Immunology]]''' | ||
− | + | {{tp|p=32361250|t=2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients |pdf=|usr=}} | |
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | ||
Zeile 37: | Zeile 41: | ||
{{tp|p=32188484|t=2020. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan |pdf=|usr=}} | {{tp|p=32188484|t=2020. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan |pdf=|usr=}} | ||
{{tp|p=32345311|t=2020. Clinical determinants for fatality of 44,672 patients with COVID-19 |pdf=|usr=}} | {{tp|p=32345311|t=2020. Clinical determinants for fatality of 44,672 patients with COVID-19 |pdf=|usr=}} | ||
− | + | {{tp|p=32295661|t=ä. Investigating the Determinants of High Case-Fatality Rate for Coronavirus Disease 2019 in Italy |pdf=|usr=}} | |
*'''[[ARDS]]''' | *'''[[ARDS]]''' | ||
Zeile 49: | Zeile 53: | ||
*'''[[Pulmonary embolism, coagulation]]''' | *'''[[Pulmonary embolism, coagulation]]''' | ||
+ | {{tp|p=32334995|t=2020. Concomitant acute aortic thrombosis and pulmonary embolism complicating COVID-19 pneumonia |pdf=|usr=}} | ||
+ | {{tp|p=32303472|t=ä. Acute pulmonary embolism in a patient with COVID-19 pneumonia |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | |||
*'''[[Hematology]]''' | *'''[[Hematology]]''' | ||
{{tp|p=32178975|t=ä. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis |pdf=|usr=}} | {{tp|p=32178975|t=ä. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis |pdf=|usr=}} | ||
Zeile 56: | Zeile 65: | ||
{{tp|p=32331780|t=ä. COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging |pdf=|usr=}} | {{tp|p=32331780|t=ä. COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging |pdf=|usr=}} | ||
{{tp|p=32318865|t=2020. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response |pdf=|usr=}} | {{tp|p=32318865|t=2020. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response |pdf=|usr=}} | ||
− | + | {{tp|p=32247212|t=2020. Cardiovascular disease and COVID-19 |pdf=|usr=}} | |
*'''[[Neurology, ophthalmology, orl]]''' | *'''[[Neurology, ophthalmology, orl]]''' | ||
+ | {{tp|p=32283980|t=2020. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms |pdf=|usr=}} | ||
+ | {{tp|p=32269598|t=2020. Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?|pdf=|usr=}} | ||
+ | |||
*'''[[Dermatology]]''' | *'''[[Dermatology]]''' | ||
*'''[[Gastroenterology, hepatology]]''' | *'''[[Gastroenterology, hepatology]]''' | ||
+ | {{tp|p=32347027|t=2020. Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports |pdf=|usr=}} | ||
+ | {{tp|p=32347435|t=ä. SARS-CoV-2-Induced Vomiting as Onset Symptom in a Patient with COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32285321|t=ä. A Call to Action: Novel Ways that Hepatologists Can Contribute to Patient Care During the COVID-19 Pandemic |pdf=|usr=}} | ||
*'''[[Kidney, urology]]== | *'''[[Kidney, urology]]== | ||
Zeile 77: | Zeile 92: | ||
{{tp|p=32326952|t=2020. SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression |pdf=|usr=}} | {{tp|p=32326952|t=2020. SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression |pdf=|usr=}} | ||
{{tp|p=32313785|t=ä. A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19 |pdf=|usr=}} | {{tp|p=32313785|t=ä. A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19 |pdf=|usr=}} | ||
+ | {{tp|p=32295707|t=ä. Fast and simple high-throughput testing of COVID 19 |pdf=|usr=}} | ||
+ | {{tp|p=32197339|t=2020. Point-of-Care RNA-Based Diagnostic Device for COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32260471|t=2020. In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends |pdf=|usr=}} | ||
+ | {{tp|p=32316113|t=2020. Combining Point-of-Care Diagnostics and Internet of Medical Things (IoMT) to Combat the COVID-19 Pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32244841|t=2020. Blockchain and Artificial Intelligence Technology for Novel Coronavirus Disease-19 Self-Testing |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
*'''[[Diagnosis (Lung CT, Sonography)]]''' | *'''[[Diagnosis (Lung CT, Sonography)]]''' | ||
+ | {{tp|p=32362428|t=2020. Lessons learned from chest CT in COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32291197|t=2020. COVID-19 pneumonia: A review of typical CT findings and differential diagnosis |pdf=|usr=}} | ||
+ | {{tp|p=32352916|t=2020. "Reversed halo sign" on 3D CT in COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32352917|t=2020. Radiological approach to COVID-19 pneumonia with an emphasis on chest CT |pdf=|usr=}} | ||
+ | {{tp|p=32352918|t=2020. Targeted early chest CT in COVID-19 outbreaks as diagnostic tool for containment of the pandemic- A multinational opinion |pdf=|usr=}} | ||
+ | {{tp|p=32352920|t=2020. MRI appearance of COVID-19 infection |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | |||
*'''[[Diagnosis (other modalities)]]''' | *'''[[Diagnosis (other modalities)]]''' | ||
{{tp|p=32276598|t=2020. Using echocardiography to guide the treatment of novel coronavirus pneumonia |pdf=|usr=}} | {{tp|p=32276598|t=2020. Using echocardiography to guide the treatment of novel coronavirus pneumonia |pdf=|usr=}} | ||
*'''[[Clinical guidelines and advice]]''' | *'''[[Clinical guidelines and advice]]''' | ||
+ | {{tp|p=32360077|t=ä. Estimating severe and critical illness in children with COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32311646|t=ä. COVID-19 admissions calculators: General population and paediatric cohort |pdf=|usr=}} | ||
+ | {{tp|p=32344199|t=2020. Sedating ventilated COVID-19 patients with inhalational anesthetic drugs |pdf=|usr=}} | ||
+ | |||
*'''[[Respiration mgmt]]''' | *'''[[Respiration mgmt]]''' | ||
{{tp|p=32371555|t=2020. Utility of extracorporeal membrane oxygenation in COVID-19 |pdf=|usr=}} | {{tp|p=32371555|t=2020. Utility of extracorporeal membrane oxygenation in COVID-19 |pdf=|usr=}} | ||
Zeile 91: | Zeile 129: | ||
*'''[[Risk and special populations]]''' | *'''[[Risk and special populations]]''' | ||
− | + | {{tp|p=32300516|t=ä. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times |pdf=|usr=}} | |
− | + | {{tp|p=32247213|t=2020. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc) |pdf=|usr=}} | |
+ | {{tp|p=32298981|t=2020. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations |pdf=|usr=}} | ||
+ | {{tp|p=32283499|t=2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers |pdf=|usr=}} | ||
+ | {{tp|p=32334395|t=ä. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia ? A systematic review, meta-analysis, and meta-regression? |pdf=|usr=}} | ||
+ | {{tp|p=32228738|t=ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease |pdf=|usr=}} | ||
+ | {{tp|p=32213760|t=2020. Facts and reflections on COVID-19 and anti-hypertensives drugs |pdf=|usr=}} | ||
+ | {{tp|p=32303915|t=ä. Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?|pdf=|usr=}} | ||
+ | {{tp|p=C7143201|t=ä. Preventive measures and management of COVID-19 in pregnancy |pdf=|usr=}} | ||
+ | {{tp|p=32323279|t=2020. Renin-Angiotensin-System (RAS) und COVID-19 - Zur Verordnung von RAS-Blockern |pdf=|usr=}} | ||
+ | {{tp|p=32256706|t=2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?|pdf=|usr=}} | ||
+ | {{tp|p=32256705|t=2020. Associations between immune-suppressive and stimulating drugs and novel COVID-19?a systematic review of current evidence |pdf=|usr=}} | ||
*'''[[Case reports]]''' | *'''[[Case reports]]''' | ||
+ | {{tp|p=32241316|t=ä. Case Report on Early Diagnosis of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32343659|t=2020. A Moderate Case of COVID-19 Viral Pneumonia During the SARS-CoV-2 Pandemic |pdf=|usr=}} | ||
*'''[[Case series]]''' | *'''[[Case series]]''' | ||
+ | {{tp|p=32337324|t=2020. The Data set for Patient Information Based Algorithm to Predict Mortality Cause by COVID-19 |pdf=|usr=}} | ||
+ | |||
*'''[[Trials]]''' | *'''[[Trials]]''' | ||
*'''[[Candidate Compounds Covid19]]''' | *'''[[Candidate Compounds Covid19]]''' | ||
+ | {{tp|p=32337328|t=2020. Coronaviruses: A patent dataset report for research and development (R&D) analysis |pdf=|usr=}} | ||
+ | {{tp|p=32247211|t=2020. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries |pdf=|usr=}} | ||
+ | {{tp|p=32335366|t=2020. Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis |pdf=|usr=}} | ||
+ | {{tp|p=32333972|t=ä. Letter to the Editor in response to the article ?COVID-19 and diabetes: Can DPP4 inhibition play a role?? |pdf=|usr=}} | ||
+ | {{tp|p=32333966|t=2020. COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications |pdf=|usr=}} | ||
+ | {{tp|p=32333969|t=ä. Response to COVID -19 and Diabetes: Can DPP4 Inhibition Play a Role? ? GLP-1 Might Play One Too |pdf=|usr=}} | ||
+ | {{tp|p=32283128|t=ä. Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?|pdf=|usr=}} ''on ace2 via adam17, nfkb via dpp4'' | ||
+ | {{tp|p=32309622|t=ä. Emerging Therapeutic Strategies for COVID-19 patients |pdf=|usr=}} | ||
+ | {{tp|p=32336723|t=2020. Treatment of SARS-CoV-2: How far have we reached?|pdf=|usr=}} | ||
+ | {{tp|p=32321878|t=2020. Is GSK3beta a molecular target of chloroquine treatment against COVID-19?|pdf=|usr=}} | ||
+ | {{tp|p=32378648|t=2020. Rapid review for the anti-coronavirus effect of remdesivir |pdf=|usr=}} | ||
+ | {{tp|p=32378647|t=2020. Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?|pdf=|usr=}} | ||
+ | {{tp|p=32147628|t=2020. Discovering drugs to treat coronavirus disease 2019 (COVID-19) |pdf=|usr=}} | ||
+ | {{tp|p=32371138|t=ä. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32198066|t=ä. Advance of promising targets and agents against COVID-19 in China |pdf=|usr=}} | ||
+ | {{tp|p=32325124|t=ä. Vaporization, bioactive formulations and a marine natural product: different perspectives on antivirals |pdf=|usr=}} | ||
+ | {{tp|p=32320852|t=ä. Deja vu: Stimulating open drug discovery for SARS-CoV-2 |pdf=|usr=}} | ||
+ | {{tp|p=32304645|t=ä. Boosting the arsenal against COVID-19 through computational drug repurposing |pdf=|usr=}} | ||
+ | {{tp|p=32266694|t=ä. Chloroquine for COVID-19 Infection |pdf=|usr=}} | ||
+ | {{tp|p=32373183|t=2020. Chloroquine and hydroxychloroquine in the context of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32343658|t=2020. Medication for COVID-19-an Overview of Approaches Currently Under Study |pdf=|usr=}} | ||
+ | {{tp|p=32344202|t=2020. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development |pdf=|usr=}} | ||
+ | {{tp|p=32249203|t=ä. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development |pdf=|usr=}} | ||
+ | |||
*'''[[The morbid survivor]]''' | *'''[[The morbid survivor]]''' | ||
Zeile 111: | Zeile 187: | ||
{{tp|p=32166318|t=ä. Protecting Health Care Workers during the COVID-19 Coronavirus Outbreak ?Lessons from Taiwan s SARS response |pdf=|usr=}} | {{tp|p=32166318|t=ä. Protecting Health Care Workers during the COVID-19 Coronavirus Outbreak ?Lessons from Taiwan s SARS response |pdf=|usr=}} | ||
{{tp|p=32354653|t=ä. COVID-19 Pandemic: Survey of future use of personal protective equipment in optometric practice |pdf=|usr=}} | {{tp|p=32354653|t=ä. COVID-19 Pandemic: Survey of future use of personal protective equipment in optometric practice |pdf=|usr=}} | ||
− | + | {{tp|p=32354631|t=ä. 3D-printed face protective shield in interventional radiology: evaluation of an immediate solution in the era of COVID-19 pandemic |pdf=|usr=}} | |
+ | {{tp|p=32223776|t=ä. A Randomized Trial of Instructor-Led Training Versus Video Lesson in Training Health Care Providers in Proper Donning and Doffing of Personal Protective Equipment |pdf=|usr=}} | ||
+ | {{tp|p=32352874|t=2020. Nasal Pressure Injuries During the COVID-19 Epidemic |pdf=|usr=}} | ||
* | * | ||
*'''[[Running your hospital]]''' | *'''[[Running your hospital]]''' | ||
+ | {{tp|p=32172175|t=2020. Clinical considerations for patients with diabetes in times of COVID-19 epidemic |pdf=|usr=}} | ||
+ | {{tp|p=32283497|t=ä. Telemedicine for Diabetes Care in India during COVID19 Pandemic and National Lockdown Period: Guidelines for Physicians |pdf=|usr=}} | ||
+ | {{tp|p=32344370|t=2020. Industry 4 0 technologies and their applications in fighting COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32305399|t=ä. COVID-19 and diabetes management: What should be considered?|pdf=|usr=}} | ||
+ | {{tp|p=32351631|t=ä. The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak |pdf=|usr=}} | ||
+ | {{tp|p=32229433|t=2020. Interventional radiology and COVID-19: evidence-based measures to limit transmission |pdf=|usr=}} | ||
+ | {{tp|p=32229434|t=2020. How imaging should properly be used in COVID-19 outbreak: an Italian experience |pdf=|usr=}} | ||
+ | {{tp|p=32359930|t=2020. COVID-19 pandemic: A stress test for interventional radiology |pdf=|usr=}} | ||
+ | {{tp|p=32360351|t=ä. Interventional oncology at the time of COVID-19 pandemic: problems and solutions |pdf=|usr=}} | ||
+ | {{tp|p=32209526|t=2020. Management strategy of novel coronavirus (COVID-19) pneumonia in the radiology department: a Chinese experience |pdf=|usr=}} | ||
+ | {{tp|p=32352919|t=2020. Imaging and COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32352915|t=2020. Strategies for radiology departments in handling the COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32363528|t=ä. Going Viral: Management of IBD in the Era of the COVID-19 Pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32323071|t=ä. Emergency Endoscopy During the SARS-CoV-2 Pandemic in the North of Italy: Experience from St Orsola University Hospital?Bologna |pdf=|usr=}} | ||
+ | {{tp|p=32338645|t=2020. ISIDOG Recommendations Concerning COVID-19 and Pregnancy |pdf=|usr=}} | ||
+ | {{tp|p=32276846|t=ä. Challenges in paediatric inflammatory bowel diseases in the COVID-19 time |pdf=|usr=}} | ||
+ | {{tp|p=32291167|t=ä. Covid-19 and cancer patients: Choosing wisely is the key |pdf=|usr=}} | ||
+ | {{tp|p=32360134|t=2020. EUS-guided gallbladder drainage during a pandemic crisis - How the COVID-19 outbreak could impact interventional endoscopy |pdf=|usr=}} | ||
+ | {{tp|p=32360133|t=ä. Screening for Active COVID-19 Infection and Immunization Status Prior to Biologic Therapy in IBD Patients at the Time of the Pandemic Outbreak |pdf=|usr=}} | ||
+ | {{tp|p=32322892|t=ä. Esophageal oncologic surgery in SARS-CoV-2 (COVID-19) emergency |pdf=|usr=}} | ||
+ | {{tp|p=32207676|t=ä. COVID-19 Epidemic in the Middle Province of Northern Italy: Impact, Logistics, and Strategy in the First Line Hospital |pdf=|usr=}} | ||
+ | {{tp|p=32216865|t=ä. Translating COVID-19 Pandemic Surge Theory to Practice in the Emergency Department: How to Expand Structure |pdf=|usr=}} | ||
+ | {{tp|p=32317038|t=ä. Coronavirus Disease 2019 Pandemic: Health System and Community Response to a Text Message (Text4Hope) Program Supporting Mental Health in Alberta |pdf=|usr=}} | ||
+ | {{tp|p=32295659|t=ä. Drawing on Israel?s Experience Organizing Volunteers to Operationalize Drive-Through Coronavirus Testing Centers |pdf=|usr=}} | ||
+ | {{tp|p=32295658|t=ä. Shelter Hospital: Glimmers of Hope in Treating Coronavirus 2019 |pdf=|usr=}} | ||
+ | {{tp|p=32234108|t=ä. How to Surge to Face the SARS-CoV-2 Outbreak: Lessons Learned From Lombardy, Italy |pdf=|usr=}} | ||
+ | {{tp|p=32344439|t=2020. COVID-19-Versorgung - Strategien der Taskforce Coronavirus und Erfahrungen von den ersten 115 Fallen am Universitatsklinikum Freiburg |pdf=|usr=}} | ||
+ | {{tp|p=32236913|t=2020. Rechtsfragen der Ressourcenzuteilung in der COVID-19-Pandemie - Zwischen Utilitarismus und Lebenswertindifferenz |pdf=|usr=}} | ||
+ | {{tp|p=32347112|t=2020. The Effects of the COVID-19/SARS-CoV-2 Pandemic Outbreak on Otolaryngology Activity in Italy |pdf=|usr=}} | ||
+ | {{tp|p=32360075|t=ä. COVID-19 admissions calculators - revisited |pdf=|usr=}} | ||
+ | {{tp|p=32368252|t=2020. Neoadjuvant endocrine therapy for luminal breast cancer treatment: a first-choice alternative in times of crisis such as the COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32346393|t=2020. COVID-19 and its ramifications for cancer patients in low-resource settings: Ghana as a case study |pdf=|usr=}} | ||
+ | {{tp|p=32269597|t=2020. Upheaval in cancer care during the COVID-19 outbreak |pdf=|usr=}} | ||
+ | {{tp|p=32346394|t=2020. Additional challenges faced by cancer patients in Gaza due to COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32346392|t=2020. Cancer care in the time of COVID-19?a perspective from Pakistan |pdf=|usr=}} | ||
*'''[[Mental aspects of health professionals]]''' | *'''[[Mental aspects of health professionals]]''' | ||
+ | {{tp|p=32248083|t=2020. Doctors and healthcare workers at frontline of COVID 19 epidemic: Admiration, a pat on the back, and need for extreme caution |pdf=|usr=}} | ||
+ | {{tp|p=32229646|t=2020. Staff Mental Health Self-Assessment During the COVID-19 Outbreak |pdf=|usr=}} | ||
− | |||
+ | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | ||
+ | {{tp|p=32314954|t=ä. COVID-19 Community Stabilization and Sustainability Framework: An Integration of the Maslow Hierarchy of Needs and Social Determinants of Health |pdf=|usr=}} | ||
+ | {{tp|p=32274787|t=2020. Psychische Probleme in der Pandemie - Beobachtungen wahrend der COVID-19-Krise |pdf=|usr=}} | ||
*'''[[Avoiding clinical medicine in other diseases]]''' | *'''[[Avoiding clinical medicine in other diseases]]''' | ||
Zeile 136: | Zeile 253: | ||
*'''[[Epidemiology]]''' | *'''[[Epidemiology]]''' | ||
+ | {{tp|p=32346568|t=2020. COVID-19 in Italy: Dataset of the Italian Civil Protection Department |pdf=|usr=}} | ||
+ | {{tp|p=32181302|t=2020. Application of the ARIMA model on the COVID-2019 epidemic dataset |pdf=|usr=}} | ||
+ | {{tp|p=32347022|t=2020. The Outbreak of COVID-19 and Diabetes in Korea: ?We Will Find a Way as We Have Always Done? |pdf=|usr=}} | ||
+ | {{tp|p=32298982|t=2020. Linear Regression Analysis to predict the number of deaths in India due to SARS-CoV-2 at 6 weeks from day 0 (100 cases - March 14th 2020) |pdf=|usr=}} | ||
+ | {{tp|p=32209502|t=2020. Novel coronavirus SARS-CoV-2: familial spread resulting in COVID-19 pneumonia in a pediatric patient |pdf=|usr=}} | ||
+ | {{tp|p=32228732|t=ä. Epidemiological Characteristics on the Clustering Nature of COVID-19 in Qingdao City, 2020: A Descriptive Analysis |pdf=|usr=}} | ||
+ | {{tp|p=32223774|t=ä. Roadblocks to Infection Prevention Efforts in Health Care: SARS-CoV-2/COVID-19 Response |pdf=|usr=}} | ||
+ | {{tp|p=32207674|t=ä. Chronology of COVID-19 Cases on the Diamond Princess Cruise Ship and Ethical Considerations: A Report From Japan |pdf=|usr=}} | ||
+ | {{tp|p=32241325|t=ä. How Is COVID-19 Affecting South Korea? What Is Our Current Strategy?|pdf=|usr=}} | ||
+ | {{tp|p=32317041|t=ä. Management of COVID-19 Outbreak in Argentina: The Beginning |pdf=|usr=}} | ||
+ | {{tp|p=32295652|t=ä. Preparedness is Essential for Western Pacific Islands During the COVID-19 Pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32285765|t=ä. Public Education and Electronic Awareness of the New Coronavirus (COVID-19): Experiences From Iran |pdf=|usr=}} | ||
+ | {{tp|p=32292266|t=ä. Preventing COVID-19 in low- and middle-income countries |pdf=|usr=}} | ||
+ | {{tp|p=32234107|t=ä. Epidemiologic Features of 135 Patients With Coronavirus Disease (COVID-19) in Tianjin, China |pdf=|usr=}} | ||
+ | {{tp|p=32344440|t=2020. Epidemiologie und Kontrollmassnahmen bei COVID-19 |pdf=|usr=}} | ||
*'''[[Failure of politics and public health guidance]]''' | *'''[[Failure of politics and public health guidance]]''' | ||
{{tp|p=32246996|t=ä. The SARS-CoV-2 epidemic: how the Italian public is being informed |pdf=|usr=}} | {{tp|p=32246996|t=ä. The SARS-CoV-2 epidemic: how the Italian public is being informed |pdf=|usr=}} | ||
{{tp|p=32292239|t=2020. Unpacking the black box: How to promote citizen engagement through government social media during the COVID-19 crisis |pdf=|usr=}} | {{tp|p=32292239|t=2020. Unpacking the black box: How to promote citizen engagement through government social media during the COVID-19 crisis |pdf=|usr=}} | ||
+ | {{tp|p=32252845|t=ä. Adaptation of the National Plan for the Prevention and Fight Against Pandemic Influenza to the 2020 COVID-19 Epidemic in France |pdf=|usr=}} | ||
+ | |||
*'''[[Failure of executive measures]]''' | *'''[[Failure of executive measures]]''' | ||
*'''[[Political abuse of Covid19]]''' | *'''[[Political abuse of Covid19]]''' | ||
{{tp|p=C7152572|t=ä. Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter |pdf=|usr=}} | {{tp|p=C7152572|t=ä. Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter |pdf=|usr=}} | ||
+ | {{tp|p=32241328|t=ä. Limited Early Warnings and Public Attention to Coronavirus Disease 2019 in China, January?February, 2020: A Longitudinal Cohort of Randomly Sampled Weibo Users |pdf=|usr=}} | ||
+ | |||
*'''[[Lost people]]''' | *'''[[Lost people]]''' | ||
Zeile 152: | Zeile 288: | ||
*[[coviki state of development]] | *[[coviki state of development]] | ||
*'''[[misc.]]''' | *'''[[misc.]]''' | ||
+ | {{tp|p=32283498|t=2020. COVID-19: From bench to bed side |pdf=|usr=}} | ||
+ | {{tp|p=32313668|t=2020. COVID-19: A new digital dawn?|pdf=|usr=}} | ||
+ | {{tp|p=32252856|t=ä. Is There a Guarantee That the Crisis of COVID-19 Will not Be Repeated?|pdf=|usr=}} | ||
+ | {{tp|p=32241329|t=ä. Global Health Security Alliance (GloHSA) |pdf=|usr=}} | ||
+ | {{tp|p=32360076|t=ä. Fatherhood during the COVID-19 pandemic: an unexpected turnaround |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[from the ads]]''' | *'''[[from the ads]]''' | ||
*[http://www.okaybio.com covid19 antibodies, proteins & reagents] | *[http://www.okaybio.com covid19 antibodies, proteins & reagents] | ||
+ | *[http://www.reactionbiology.com 700 kinsse assays] |
Version vom 20. Mai 2020, 19:54 Uhr
32335367 ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
32142596 2020. Machine Learning, COVID?19 (2019?nCoV), and multi?OMICS
32187834 2020. ..COVID19: Cytometry and the New Challenge for Global Health
32311462 2020. On the molecular determinants of the SARS-CoV-2 attack
32129843 ä. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients
32129842 ä. A glimpse into the origins of genetic diversity in SARS-CoV-2
32229288 ä. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy
32341946 2020. Chaos game representation dataset of SARS-CoV-2 genome
32220422 2020. The hosts angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections
32271376 ä. Factors associated with prolonged viral RNA shedding in patients with COVID-19
32361250 2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
32358954 ä. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing
32361747 ä. COVID-19, superinfections and antimicrobial development: What can we expect?
32188484 2020. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan
32345311 2020. Clinical determinants for fatality of 44,672 patients with COVID-19
32295661 ä. Investigating the Determinants of High Case-Fatality Rate for Coronavirus Disease 2019 in Italy
32173725 ä. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China
32161968 ä. A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias
32271373 ä. Predictors of refractory Coronavirus disease (COVID-19) pneumonia
32375845 2020. Acute respiratory failure in COVID-19: is it ?typical? ARDS?
32299472 2020. COVID-19 pneumonia: ARDS or not?
32351860 ä. Coronavirus Disease 2019 (COVID-19) Complicated by Acute Respiratory Distress Syndrome: An Internist?s Perspective
32334995 2020. Concomitant acute aortic thrombosis and pulmonary embolism complicating COVID-19 pneumonia
32303472 ä. Acute pulmonary embolism in a patient with COVID-19 pneumonia
32178975 ä. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
32371557 2020. SARS-CoV-2 and myocardial injury: Few answers, many questions
32331780 ä. COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging
32318865 2020. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response
32247212 2020. Cardiovascular disease and COVID-19
32283980 2020. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms
32269598 2020. Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
32347027 2020. Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports
32347435 ä. SARS-CoV-2-Induced Vomiting as Onset Symptom in a Patient with COVID-19
32285321 ä. A Call to Action: Novel Ways that Hepatologists Can Contribute to Patient Care During the COVID-19 Pandemic
32299479 2020. Acute kidney injury in SARS-CoV-2 infected patients
32215622 ä. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility
32326952 2020. SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression
32313785 ä. A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19
32295707 ä. Fast and simple high-throughput testing of COVID 19
32197339 2020. Point-of-Care RNA-Based Diagnostic Device for COVID-19
32260471 2020. In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends
32316113 2020. Combining Point-of-Care Diagnostics and Internet of Medical Things (IoMT) to Combat the COVID-19 Pandemic
32244841 2020. Blockchain and Artificial Intelligence Technology for Novel Coronavirus Disease-19 Self-Testing
32362428 2020. Lessons learned from chest CT in COVID-19
32291197 2020. COVID-19 pneumonia: A review of typical CT findings and differential diagnosis
32352916 2020. "Reversed halo sign" on 3D CT in COVID-19
32352917 2020. Radiological approach to COVID-19 pneumonia with an emphasis on chest CT
32352918 2020. Targeted early chest CT in COVID-19 outbreaks as diagnostic tool for containment of the pandemic- A multinational opinion
32352920 2020. MRI appearance of COVID-19 infection
32276598 2020. Using echocardiography to guide the treatment of novel coronavirus pneumonia
32360077 ä. Estimating severe and critical illness in children with COVID-19
32311646 ä. COVID-19 admissions calculators: General population and paediatric cohort
32344199 2020. Sedating ventilated COVID-19 patients with inhalational anesthetic drugs
32371555 2020. Utility of extracorporeal membrane oxygenation in COVID-19
32357995 2020. Tracheal intubation in patients with COVID-19
32326959 2020. High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients
C7156900 2020. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series
32300516 ä. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times
32247213 2020. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)
32298981 2020. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
32283499 2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
32334395 ä. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia ? A systematic review, meta-analysis, and meta-regression?
32228738 ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease
32213760 2020. Facts and reflections on COVID-19 and anti-hypertensives drugs
32303915 ä. Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
C7143201 ä. Preventive measures and management of COVID-19 in pregnancy
32323279 2020. Renin-Angiotensin-System (RAS) und COVID-19 - Zur Verordnung von RAS-Blockern
32256706 2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
32256705 2020. Associations between immune-suppressive and stimulating drugs and novel COVID-19?a systematic review of current evidence
32241316 ä. Case Report on Early Diagnosis of COVID-19
32343659 2020. A Moderate Case of COVID-19 Viral Pneumonia During the SARS-CoV-2 Pandemic
32337324 2020. The Data set for Patient Information Based Algorithm to Predict Mortality Cause by COVID-19
32337328 2020. Coronaviruses: A patent dataset report for research and development (R&D) analysis
32247211 2020. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries
32335366 2020. Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis
32333972 ä. Letter to the Editor in response to the article ?COVID-19 and diabetes: Can DPP4 inhibition play a role??
32333966 2020. COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications
32333969 ä. Response to COVID -19 and Diabetes: Can DPP4 Inhibition Play a Role? ? GLP-1 Might Play One Too
32283128 ä. Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? on ace2 via adam17, nfkb via dpp4
32309622 ä. Emerging Therapeutic Strategies for COVID-19 patients
32336723 2020. Treatment of SARS-CoV-2: How far have we reached?
32321878 2020. Is GSK3beta a molecular target of chloroquine treatment against COVID-19?
32378648 2020. Rapid review for the anti-coronavirus effect of remdesivir
32378647 2020. Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?
32147628 2020. Discovering drugs to treat coronavirus disease 2019 (COVID-19)
32371138 ä. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19
32198066 ä. Advance of promising targets and agents against COVID-19 in China
32325124 ä. Vaporization, bioactive formulations and a marine natural product: different perspectives on antivirals
32320852 ä. Deja vu: Stimulating open drug discovery for SARS-CoV-2
32304645 ä. Boosting the arsenal against COVID-19 through computational drug repurposing
32266694 ä. Chloroquine for COVID-19 Infection
32373183 2020. Chloroquine and hydroxychloroquine in the context of COVID-19
32343658 2020. Medication for COVID-19-an Overview of Approaches Currently Under Study
32344202 2020. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
32249203 ä. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
32241022 ä. SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection
32297915 ä. Comment of the potential risks of sexual and vertical transmission of Covid-19 infection
32315026 ä. Responding to the COVID-19 outbreak in Singapore: Staff Protection and Staff Temperature and Sickness Surveillance Systems
32166318 ä. Protecting Health Care Workers during the COVID-19 Coronavirus Outbreak ?Lessons from Taiwan s SARS response
32354653 ä. COVID-19 Pandemic: Survey of future use of personal protective equipment in optometric practice
32354631 ä. 3D-printed face protective shield in interventional radiology: evaluation of an immediate solution in the era of COVID-19 pandemic
32223776 ä. A Randomized Trial of Instructor-Led Training Versus Video Lesson in Training Health Care Providers in Proper Donning and Doffing of Personal Protective Equipment
32352874 2020. Nasal Pressure Injuries During the COVID-19 Epidemic
32172175 2020. Clinical considerations for patients with diabetes in times of COVID-19 epidemic
32283497 ä. Telemedicine for Diabetes Care in India during COVID19 Pandemic and National Lockdown Period: Guidelines for Physicians
32344370 2020. Industry 4 0 technologies and their applications in fighting COVID-19 pandemic
32305399 ä. COVID-19 and diabetes management: What should be considered?
32351631 ä. The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak
32229433 2020. Interventional radiology and COVID-19: evidence-based measures to limit transmission
32229434 2020. How imaging should properly be used in COVID-19 outbreak: an Italian experience
32359930 2020. COVID-19 pandemic: A stress test for interventional radiology
32360351 ä. Interventional oncology at the time of COVID-19 pandemic: problems and solutions
32209526 2020. Management strategy of novel coronavirus (COVID-19) pneumonia in the radiology department: a Chinese experience
32352919 2020. Imaging and COVID-19
32352915 2020. Strategies for radiology departments in handling the COVID-19 pandemic
32363528 ä. Going Viral: Management of IBD in the Era of the COVID-19 Pandemic
32323071 ä. Emergency Endoscopy During the SARS-CoV-2 Pandemic in the North of Italy: Experience from St Orsola University Hospital?Bologna
32338645 2020. ISIDOG Recommendations Concerning COVID-19 and Pregnancy
32276846 ä. Challenges in paediatric inflammatory bowel diseases in the COVID-19 time
32291167 ä. Covid-19 and cancer patients: Choosing wisely is the key
32360134 2020. EUS-guided gallbladder drainage during a pandemic crisis - How the COVID-19 outbreak could impact interventional endoscopy
32360133 ä. Screening for Active COVID-19 Infection and Immunization Status Prior to Biologic Therapy in IBD Patients at the Time of the Pandemic Outbreak
32322892 ä. Esophageal oncologic surgery in SARS-CoV-2 (COVID-19) emergency
32207676 ä. COVID-19 Epidemic in the Middle Province of Northern Italy: Impact, Logistics, and Strategy in the First Line Hospital
32216865 ä. Translating COVID-19 Pandemic Surge Theory to Practice in the Emergency Department: How to Expand Structure
32317038 ä. Coronavirus Disease 2019 Pandemic: Health System and Community Response to a Text Message (Text4Hope) Program Supporting Mental Health in Alberta
32295659 ä. Drawing on Israel?s Experience Organizing Volunteers to Operationalize Drive-Through Coronavirus Testing Centers
32295658 ä. Shelter Hospital: Glimmers of Hope in Treating Coronavirus 2019
32234108 ä. How to Surge to Face the SARS-CoV-2 Outbreak: Lessons Learned From Lombardy, Italy
32344439 2020. COVID-19-Versorgung - Strategien der Taskforce Coronavirus und Erfahrungen von den ersten 115 Fallen am Universitatsklinikum Freiburg
32236913 2020. Rechtsfragen der Ressourcenzuteilung in der COVID-19-Pandemie - Zwischen Utilitarismus und Lebenswertindifferenz
32347112 2020. The Effects of the COVID-19/SARS-CoV-2 Pandemic Outbreak on Otolaryngology Activity in Italy
32360075 ä. COVID-19 admissions calculators - revisited
32368252 2020. Neoadjuvant endocrine therapy for luminal breast cancer treatment: a first-choice alternative in times of crisis such as the COVID-19 pandemic
32346393 2020. COVID-19 and its ramifications for cancer patients in low-resource settings: Ghana as a case study
32269597 2020. Upheaval in cancer care during the COVID-19 outbreak
32346394 2020. Additional challenges faced by cancer patients in Gaza due to COVID-19
32346392 2020. Cancer care in the time of COVID-19?a perspective from Pakistan
32248083 2020. Doctors and healthcare workers at frontline of COVID 19 epidemic: Admiration, a pat on the back, and need for extreme caution
32229646 2020. Staff Mental Health Self-Assessment During the COVID-19 Outbreak
32314954 ä. COVID-19 Community Stabilization and Sustainability Framework: An Integration of the Maslow Hierarchy of Needs and Social Determinants of Health
32274787 2020. Psychische Probleme in der Pandemie - Beobachtungen wahrend der COVID-19-Krise
- Avoiding clinical medicine in other diseases
- Occupational medicine, workplace security and status hygienicus
- Economic aspects of the status hygienicus
- Educational aspects of the status hygienicus
- Host, vector, one health, atmospheric aspects
- Origin of Covid19
32315626 2020. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
32346568 2020. COVID-19 in Italy: Dataset of the Italian Civil Protection Department
32181302 2020. Application of the ARIMA model on the COVID-2019 epidemic dataset
32347022 2020. The Outbreak of COVID-19 and Diabetes in Korea: ?We Will Find a Way as We Have Always Done?
32298982 2020. Linear Regression Analysis to predict the number of deaths in India due to SARS-CoV-2 at 6 weeks from day 0 (100 cases - March 14th 2020)
32209502 2020. Novel coronavirus SARS-CoV-2: familial spread resulting in COVID-19 pneumonia in a pediatric patient
32228732 ä. Epidemiological Characteristics on the Clustering Nature of COVID-19 in Qingdao City, 2020: A Descriptive Analysis
32223774 ä. Roadblocks to Infection Prevention Efforts in Health Care: SARS-CoV-2/COVID-19 Response
32207674 ä. Chronology of COVID-19 Cases on the Diamond Princess Cruise Ship and Ethical Considerations: A Report From Japan
32241325 ä. How Is COVID-19 Affecting South Korea? What Is Our Current Strategy?
32317041 ä. Management of COVID-19 Outbreak in Argentina: The Beginning
32295652 ä. Preparedness is Essential for Western Pacific Islands During the COVID-19 Pandemic
32285765 ä. Public Education and Electronic Awareness of the New Coronavirus (COVID-19): Experiences From Iran
32292266 ä. Preventing COVID-19 in low- and middle-income countries
32234107 ä. Epidemiologic Features of 135 Patients With Coronavirus Disease (COVID-19) in Tianjin, China
32344440 2020. Epidemiologie und Kontrollmassnahmen bei COVID-19
32246996 ä. The SARS-CoV-2 epidemic: how the Italian public is being informed
32292239 2020. Unpacking the black box: How to promote citizen engagement through government social media during the COVID-19 crisis
32252845 ä. Adaptation of the National Plan for the Prevention and Fight Against Pandemic Influenza to the 2020 COVID-19 Epidemic in France
C7152572 ä. Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter
32241328 ä. Limited Early Warnings and Public Attention to Coronavirus Disease 2019 in China, January?February, 2020: A Longitudinal Cohort of Randomly Sampled Weibo Users
- Lost people
- Lost civilization
- History of covid19 exploration
- Current state of coviki.org
- PubMed selected papers unsorted to be listed in contents topics
- coviki state of development
- misc.
32283498 2020. COVID-19: From bench to bed side
32313668 2020. COVID-19: A new digital dawn?
32252856 ä. Is There a Guarantee That the Crisis of COVID-19 Will not Be Repeated?
32241329 ä. Global Health Security Alliance (GloHSA)
32360076 ä. Fatherhood during the COVID-19 pandemic: an unexpected turnaround